nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—ABCG2—Lamivudine—hepatitis B	0.183	0.735	CbGbCtD
Lansoprazole—ABCB1—Lamivudine—hepatitis B	0.066	0.265	CbGbCtD
Lansoprazole—ATP4A—blood plasma—hepatitis B	0.0141	0.155	CbGeAlD
Lansoprazole—ATP4B—liver—hepatitis B	0.00929	0.102	CbGeAlD
Lansoprazole—ATP4A—blood—hepatitis B	0.00517	0.0567	CbGeAlD
Lansoprazole—CYP4A11—liver—hepatitis B	0.00502	0.055	CbGeAlD
Lansoprazole—CYP2C19—blood plasma—hepatitis B	0.00493	0.0541	CbGeAlD
Lansoprazole—CYP2C8—blood plasma—hepatitis B	0.0043	0.0472	CbGeAlD
Lansoprazole—ATP4A—liver—hepatitis B	0.00404	0.0444	CbGeAlD
Lansoprazole—CYP1A2—blood plasma—hepatitis B	0.00403	0.0442	CbGeAlD
Lansoprazole—CYP2C9—blood plasma—hepatitis B	0.00382	0.0419	CbGeAlD
Lansoprazole—CYP2C18—liver—hepatitis B	0.00332	0.0365	CbGeAlD
Lansoprazole—CYP3A4—blood plasma—hepatitis B	0.00292	0.032	CbGeAlD
Lansoprazole—CYP2D6—blood plasma—hepatitis B	0.00287	0.0315	CbGeAlD
Lansoprazole—Cramp muscle—Telbivudine—hepatitis B	0.00243	0.0048	CcSEcCtD
Lansoprazole—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00243	0.0048	CcSEcCtD
Lansoprazole—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00242	0.00479	CcSEcCtD
Lansoprazole—Haematuria—Entecavir—hepatitis B	0.00241	0.00476	CcSEcCtD
Lansoprazole—Nasopharyngitis—Telbivudine—hepatitis B	0.00241	0.00476	CcSEcCtD
Lansoprazole—Jaundice—Adefovir Dipivoxil—hepatitis B	0.0024	0.00475	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Entecavir—hepatitis B	0.00239	0.00473	CcSEcCtD
Lansoprazole—Gastritis—Telbivudine—hepatitis B	0.00238	0.00471	CcSEcCtD
Lansoprazole—Vasodilation procedure—Lamivudine—hepatitis B	0.00238	0.00471	CcSEcCtD
Lansoprazole—Vasodilation—Lamivudine—hepatitis B	0.00238	0.00471	CcSEcCtD
Lansoprazole—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00238	0.0047	CcSEcCtD
Lansoprazole—Muscular weakness—Telbivudine—hepatitis B	0.00238	0.0047	CcSEcCtD
Lansoprazole—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00235	0.00465	CcSEcCtD
Lansoprazole—Abdominal distension—Telbivudine—hepatitis B	0.00234	0.00463	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00233	0.00461	CcSEcCtD
Lansoprazole—Influenza—Telbivudine—hepatitis B	0.00233	0.0046	CcSEcCtD
Lansoprazole—Rectal haemorrhage—Lamivudine—hepatitis B	0.00232	0.00458	CcSEcCtD
Lansoprazole—Bone disorder—Lamivudine—hepatitis B	0.00232	0.00458	CcSEcCtD
Lansoprazole—Viral infection—Lamivudine—hepatitis B	0.00232	0.00458	CcSEcCtD
Lansoprazole—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00231	0.00457	CcSEcCtD
Lansoprazole—Oropharyngeal pain—Lamivudine—hepatitis B	0.0023	0.00455	CcSEcCtD
Lansoprazole—Hepatitis—Entecavir—hepatitis B	0.00227	0.00449	CcSEcCtD
Lansoprazole—Oedema peripheral—Entecavir—hepatitis B	0.00223	0.00442	CcSEcCtD
Lansoprazole—Abdominal discomfort—Telbivudine—hepatitis B	0.00223	0.00441	CcSEcCtD
Lansoprazole—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00221	0.00438	CcSEcCtD
Lansoprazole—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.0022	0.00434	CcSEcCtD
Lansoprazole—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00219	0.00432	CcSEcCtD
Lansoprazole—Neutropenia—Telbivudine—hepatitis B	0.00218	0.0043	CcSEcCtD
Lansoprazole—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00217	0.0043	CcSEcCtD
Lansoprazole—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00217	0.00429	CcSEcCtD
Lansoprazole—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00216	0.00428	CcSEcCtD
Lansoprazole—Inflammation—Lamivudine—hepatitis B	0.00216	0.00426	CcSEcCtD
Lansoprazole—Musculoskeletal pain—Lamivudine—hepatitis B	0.00212	0.00419	CcSEcCtD
Lansoprazole—ABCB1—blood plasma—hepatitis B	0.00206	0.0226	CbGeAlD
Lansoprazole—CYP1B1—blood—hepatitis B	0.00206	0.0226	CbGeAlD
Lansoprazole—Eructation—Lamivudine—hepatitis B	0.00205	0.00406	CcSEcCtD
Lansoprazole—Immune system disorder—Entecavir—hepatitis B	0.00205	0.00405	CcSEcCtD
Lansoprazole—Renal failure—Telbivudine—hepatitis B	0.00204	0.00403	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Telbivudine—hepatitis B	0.00203	0.00402	CcSEcCtD
Lansoprazole—Wheezing—Lamivudine—hepatitis B	0.00203	0.00402	CcSEcCtD
Lansoprazole—Alopecia—Entecavir—hepatitis B	0.002	0.00396	CcSEcCtD
Lansoprazole—Mental disorder—Entecavir—hepatitis B	0.00199	0.00393	CcSEcCtD
Lansoprazole—Malnutrition—Entecavir—hepatitis B	0.00197	0.0039	CcSEcCtD
Lansoprazole—Photophobia—Lamivudine—hepatitis B	0.00196	0.00388	CcSEcCtD
Lansoprazole—Aplastic anaemia—Lamivudine—hepatitis B	0.00196	0.00388	CcSEcCtD
Lansoprazole—Neuropathy—Lamivudine—hepatitis B	0.00196	0.00388	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Telbivudine—hepatitis B	0.00196	0.00388	CcSEcCtD
Lansoprazole—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00193	0.00381	CcSEcCtD
Lansoprazole—Flatulence—Adefovir Dipivoxil—hepatitis B	0.0019	0.00375	CcSEcCtD
Lansoprazole—Urine output increased—Lamivudine—hepatitis B	0.00189	0.00374	CcSEcCtD
Lansoprazole—Mouth ulceration—Lamivudine—hepatitis B	0.00189	0.00374	CcSEcCtD
Lansoprazole—Gynaecomastia—Lamivudine—hepatitis B	0.00187	0.0037	CcSEcCtD
Lansoprazole—Back pain—Adefovir Dipivoxil—hepatitis B	0.00186	0.00368	CcSEcCtD
Lansoprazole—Hepatitis—Telbivudine—hepatitis B	0.00186	0.00368	CcSEcCtD
Lansoprazole—Hypoaesthesia—Telbivudine—hepatitis B	0.00185	0.00367	CcSEcCtD
Lansoprazole—Pharyngitis—Telbivudine—hepatitis B	0.00185	0.00366	CcSEcCtD
Lansoprazole—Connective tissue disorder—Telbivudine—hepatitis B	0.00183	0.00362	CcSEcCtD
Lansoprazole—CYP2C19—blood—hepatitis B	0.00181	0.0198	CbGeAlD
Lansoprazole—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00178	0.00352	CcSEcCtD
Lansoprazole—Lymphadenopathy—Lamivudine—hepatitis B	0.00178	0.00352	CcSEcCtD
Lansoprazole—Leukopenia—Entecavir—hepatitis B	0.00177	0.00349	CcSEcCtD
Lansoprazole—Sleep disorder—Lamivudine—hepatitis B	0.00175	0.00347	CcSEcCtD
Lansoprazole—Polyuria—Lamivudine—hepatitis B	0.00173	0.00342	CcSEcCtD
Lansoprazole—Gastroenteritis—Lamivudine—hepatitis B	0.00171	0.00339	CcSEcCtD
Lansoprazole—Deafness—Lamivudine—hepatitis B	0.0017	0.00336	CcSEcCtD
Lansoprazole—Cough—Adefovir Dipivoxil—hepatitis B	0.00168	0.00332	CcSEcCtD
Lansoprazole—Mediastinal disorder—Telbivudine—hepatitis B	0.00168	0.00332	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00167	0.0033	CcSEcCtD
Lansoprazole—Injury—Lamivudine—hepatitis B	0.00165	0.00327	CcSEcCtD
Lansoprazole—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00164	0.00324	CcSEcCtD
Lansoprazole—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00164	0.00324	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00163	0.00322	CcSEcCtD
Lansoprazole—Malnutrition—Telbivudine—hepatitis B	0.00162	0.00321	CcSEcCtD
Lansoprazole—Anaphylactic shock—Entecavir—hepatitis B	0.00161	0.00319	CcSEcCtD
Lansoprazole—CYP1B1—liver—hepatitis B	0.00161	0.0177	CbGeAlD
Lansoprazole—Infection—Entecavir—hepatitis B	0.0016	0.00317	CcSEcCtD
Lansoprazole—Renal impairment—Lamivudine—hepatitis B	0.00159	0.00315	CcSEcCtD
Lansoprazole—Thirst—Lamivudine—hepatitis B	0.00159	0.00315	CcSEcCtD
Lansoprazole—Dysgeusia—Telbivudine—hepatitis B	0.00159	0.00314	CcSEcCtD
Lansoprazole—Nervous system disorder—Entecavir—hepatitis B	0.00158	0.00312	CcSEcCtD
Lansoprazole—CYP2C8—blood—hepatitis B	0.00158	0.0173	CbGeAlD
Lansoprazole—Back pain—Telbivudine—hepatitis B	0.00157	0.0031	CcSEcCtD
Lansoprazole—Skin disorder—Entecavir—hepatitis B	0.00157	0.0031	CcSEcCtD
Lansoprazole—Muscle spasms—Telbivudine—hepatitis B	0.00156	0.00308	CcSEcCtD
Lansoprazole—Hypoglycaemia—Lamivudine—hepatitis B	0.00156	0.00308	CcSEcCtD
Lansoprazole—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00154	0.00305	CcSEcCtD
Lansoprazole—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00154	0.00304	CcSEcCtD
Lansoprazole—ABCG2—blood—hepatitis B	0.00153	0.0168	CbGeAlD
Lansoprazole—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00153	0.00302	CcSEcCtD
Lansoprazole—Ill-defined disorder—Telbivudine—hepatitis B	0.0015	0.00298	CcSEcCtD
Lansoprazole—Anorexia—Adefovir Dipivoxil—hepatitis B	0.0015	0.00296	CcSEcCtD
Lansoprazole—Migraine—Lamivudine—hepatitis B	0.00149	0.00295	CcSEcCtD
Lansoprazole—Affect lability—Lamivudine—hepatitis B	0.00149	0.00295	CcSEcCtD
Lansoprazole—CYP1A2—blood—hepatitis B	0.00148	0.0162	CbGeAlD
Lansoprazole—Malaise—Telbivudine—hepatitis B	0.00146	0.00289	CcSEcCtD
Lansoprazole—Insomnia—Entecavir—hepatitis B	0.00146	0.00288	CcSEcCtD
Lansoprazole—CYP1A1—blood—hepatitis B	0.00146	0.016	CbGeAlD
Lansoprazole—Mood swings—Lamivudine—hepatitis B	0.00144	0.00284	CcSEcCtD
Lansoprazole—Somnolence—Entecavir—hepatitis B	0.00143	0.00283	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00143	0.00283	CcSEcCtD
Lansoprazole—Dyspepsia—Entecavir—hepatitis B	0.00142	0.0028	CcSEcCtD
Lansoprazole—Cough—Telbivudine—hepatitis B	0.00142	0.0028	CcSEcCtD
Lansoprazole—CYP2C19—liver—hepatitis B	0.00141	0.0155	CbGeAlD
Lansoprazole—Dehydration—Lamivudine—hepatitis B	0.00141	0.00279	CcSEcCtD
Lansoprazole—Liver function test abnormal—Lamivudine—hepatitis B	0.0014	0.00277	CcSEcCtD
Lansoprazole—CYP2C9—blood—hepatitis B	0.0014	0.0154	CbGeAlD
Lansoprazole—Gastrointestinal disorder—Entecavir—hepatitis B	0.00139	0.00275	CcSEcCtD
Lansoprazole—Fatigue—Entecavir—hepatitis B	0.00139	0.00275	CcSEcCtD
Lansoprazole—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00138	0.00274	CcSEcCtD
Lansoprazole—Myalgia—Telbivudine—hepatitis B	0.00138	0.00273	CcSEcCtD
Lansoprazole—Arthralgia—Telbivudine—hepatitis B	0.00138	0.00273	CcSEcCtD
Lansoprazole—Chest pain—Telbivudine—hepatitis B	0.00138	0.00273	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00137	0.00271	CcSEcCtD
Lansoprazole—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00137	0.0027	CcSEcCtD
Lansoprazole—Cramp muscle—Lamivudine—hepatitis B	0.00137	0.0027	CcSEcCtD
Lansoprazole—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00137	0.0027	CcSEcCtD
Lansoprazole—Discomfort—Telbivudine—hepatitis B	0.00136	0.0027	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00136	0.00268	CcSEcCtD
Lansoprazole—Nasopharyngitis—Lamivudine—hepatitis B	0.00136	0.00268	CcSEcCtD
Lansoprazole—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00134	0.00265	CcSEcCtD
Lansoprazole—Muscular weakness—Lamivudine—hepatitis B	0.00134	0.00265	CcSEcCtD
Lansoprazole—Abdominal distension—Lamivudine—hepatitis B	0.00132	0.00261	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Entecavir—hepatitis B	0.00132	0.00261	CcSEcCtD
Lansoprazole—Influenza—Lamivudine—hepatitis B	0.00131	0.00259	CcSEcCtD
Lansoprazole—Dysphagia—Lamivudine—hepatitis B	0.00131	0.00259	CcSEcCtD
Lansoprazole—Nervous system disorder—Telbivudine—hepatitis B	0.0013	0.00257	CcSEcCtD
Lansoprazole—Thrombocytopenia—Telbivudine—hepatitis B	0.0013	0.00256	CcSEcCtD
Lansoprazole—Pancreatitis—Lamivudine—hepatitis B	0.00129	0.00254	CcSEcCtD
Lansoprazole—Skin disorder—Telbivudine—hepatitis B	0.00129	0.00254	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00129	0.00254	CcSEcCtD
Lansoprazole—Abdominal pain—Entecavir—hepatitis B	0.00127	0.00252	CcSEcCtD
Lansoprazole—Body temperature increased—Entecavir—hepatitis B	0.00127	0.00252	CcSEcCtD
Lansoprazole—Bronchitis—Lamivudine—hepatitis B	0.00126	0.00249	CcSEcCtD
Lansoprazole—Abdominal discomfort—Lamivudine—hepatitis B	0.00126	0.00249	CcSEcCtD
Lansoprazole—Pancytopenia—Lamivudine—hepatitis B	0.00125	0.00246	CcSEcCtD
Lansoprazole—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00124	0.00246	CcSEcCtD
Lansoprazole—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00124	0.00246	CcSEcCtD
Lansoprazole—CYP2C8—liver—hepatitis B	0.00123	0.0135	CbGeAlD
Lansoprazole—Neutropenia—Lamivudine—hepatitis B	0.00123	0.00243	CcSEcCtD
Lansoprazole—Dysuria—Lamivudine—hepatitis B	0.00123	0.00243	CcSEcCtD
Lansoprazole—Pollakiuria—Lamivudine—hepatitis B	0.00121	0.0024	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00121	0.00238	CcSEcCtD
Lansoprazole—ABCG2—liver—hepatitis B	0.0012	0.0132	CbGeAlD
Lansoprazole—Insomnia—Telbivudine—hepatitis B	0.0012	0.00237	CcSEcCtD
Lansoprazole—Paraesthesia—Telbivudine—hepatitis B	0.00119	0.00235	CcSEcCtD
Lansoprazole—Hyperglycaemia—Lamivudine—hepatitis B	0.00118	0.00234	CcSEcCtD
Lansoprazole—Dyspepsia—Telbivudine—hepatitis B	0.00117	0.0023	CcSEcCtD
Lansoprazole—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00116	0.00229	CcSEcCtD
Lansoprazole—Asthenia—Entecavir—hepatitis B	0.00116	0.00229	CcSEcCtD
Lansoprazole—CYP1A2—liver—hepatitis B	0.00115	0.0127	CbGeAlD
Lansoprazole—Renal failure—Lamivudine—hepatitis B	0.00115	0.00227	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Lamivudine—hepatitis B	0.00115	0.00227	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00114	0.00226	CcSEcCtD
Lansoprazole—Fatigue—Telbivudine—hepatitis B	0.00114	0.00226	CcSEcCtD
Lansoprazole—Jaundice—Lamivudine—hepatitis B	0.00114	0.00225	CcSEcCtD
Lansoprazole—Stomatitis—Lamivudine—hepatitis B	0.00114	0.00225	CcSEcCtD
Lansoprazole—CYP1A1—liver—hepatitis B	0.00114	0.0125	CbGeAlD
Lansoprazole—Pain—Telbivudine—hepatitis B	0.00113	0.00224	CcSEcCtD
Lansoprazole—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00113	0.00223	CcSEcCtD
Lansoprazole—Sweating—Lamivudine—hepatitis B	0.00112	0.00222	CcSEcCtD
Lansoprazole—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00111	0.0022	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Lamivudine—hepatitis B	0.00111	0.00219	CcSEcCtD
Lansoprazole—Epistaxis—Lamivudine—hepatitis B	0.0011	0.00218	CcSEcCtD
Lansoprazole—Diarrhoea—Entecavir—hepatitis B	0.0011	0.00218	CcSEcCtD
Lansoprazole—Sinusitis—Lamivudine—hepatitis B	0.0011	0.00217	CcSEcCtD
Lansoprazole—CYP2C9—liver—hepatitis B	0.0011	0.012	CbGeAlD
Lansoprazole—Agranulocytosis—Lamivudine—hepatitis B	0.00109	0.00216	CcSEcCtD
Lansoprazole—Feeling abnormal—Telbivudine—hepatitis B	0.00109	0.00216	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Telbivudine—hepatitis B	0.00108	0.00214	CcSEcCtD
Lansoprazole—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00108	0.00213	CcSEcCtD
Lansoprazole—CYP3A4—blood—hepatitis B	0.00107	0.0117	CbGeAlD
Lansoprazole—Dizziness—Entecavir—hepatitis B	0.00107	0.00211	CcSEcCtD
Lansoprazole—Rhinitis—Lamivudine—hepatitis B	0.00105	0.00208	CcSEcCtD
Lansoprazole—CYP2D6—blood—hepatitis B	0.00105	0.0115	CbGeAlD
Lansoprazole—Hepatitis—Lamivudine—hepatitis B	0.00105	0.00208	CcSEcCtD
Lansoprazole—Body temperature increased—Telbivudine—hepatitis B	0.00105	0.00207	CcSEcCtD
Lansoprazole—Abdominal pain—Telbivudine—hepatitis B	0.00105	0.00207	CcSEcCtD
Lansoprazole—Hypoaesthesia—Lamivudine—hepatitis B	0.00104	0.00207	CcSEcCtD
Lansoprazole—Pharyngitis—Lamivudine—hepatitis B	0.00104	0.00206	CcSEcCtD
Lansoprazole—Connective tissue disorder—Lamivudine—hepatitis B	0.00103	0.00204	CcSEcCtD
Lansoprazole—Vomiting—Entecavir—hepatitis B	0.00102	0.00203	CcSEcCtD
Lansoprazole—Rash—Entecavir—hepatitis B	0.00102	0.00201	CcSEcCtD
Lansoprazole—Dermatitis—Entecavir—hepatitis B	0.00102	0.00201	CcSEcCtD
Lansoprazole—Headache—Entecavir—hepatitis B	0.00101	0.002	CcSEcCtD
Lansoprazole—Vomiting—Adefovir Dipivoxil—hepatitis B	0.001	0.00198	CcSEcCtD
Lansoprazole—Erythema multiforme—Lamivudine—hepatitis B	0.000993	0.00196	CcSEcCtD
Lansoprazole—Rash—Adefovir Dipivoxil—hepatitis B	0.000991	0.00196	CcSEcCtD
Lansoprazole—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00099	0.00196	CcSEcCtD
Lansoprazole—Headache—Adefovir Dipivoxil—hepatitis B	0.000985	0.00195	CcSEcCtD
Lansoprazole—Nausea—Entecavir—hepatitis B	0.000957	0.00189	CcSEcCtD
Lansoprazole—Asthenia—Telbivudine—hepatitis B	0.00095	0.00188	CcSEcCtD
Lansoprazole—Immune system disorder—Lamivudine—hepatitis B	0.000948	0.00188	CcSEcCtD
Lansoprazole—Mediastinal disorder—Lamivudine—hepatitis B	0.000946	0.00187	CcSEcCtD
Lansoprazole—Chills—Lamivudine—hepatitis B	0.000942	0.00186	CcSEcCtD
Lansoprazole—Pruritus—Telbivudine—hepatitis B	0.000937	0.00185	CcSEcCtD
Lansoprazole—Nausea—Adefovir Dipivoxil—hepatitis B	0.000934	0.00185	CcSEcCtD
Lansoprazole—Alopecia—Lamivudine—hepatitis B	0.000928	0.00183	CcSEcCtD
Lansoprazole—Erythema—Lamivudine—hepatitis B	0.000914	0.00181	CcSEcCtD
Lansoprazole—Malnutrition—Lamivudine—hepatitis B	0.000914	0.00181	CcSEcCtD
Lansoprazole—Diarrhoea—Telbivudine—hepatitis B	0.000906	0.00179	CcSEcCtD
Lansoprazole—Flatulence—Lamivudine—hepatitis B	0.000901	0.00178	CcSEcCtD
Lansoprazole—Tension—Lamivudine—hepatitis B	0.000897	0.00177	CcSEcCtD
Lansoprazole—Dysgeusia—Lamivudine—hepatitis B	0.000895	0.00177	CcSEcCtD
Lansoprazole—Nervousness—Lamivudine—hepatitis B	0.000888	0.00176	CcSEcCtD
Lansoprazole—Back pain—Lamivudine—hepatitis B	0.000884	0.00175	CcSEcCtD
Lansoprazole—Muscle spasms—Lamivudine—hepatitis B	0.000879	0.00174	CcSEcCtD
Lansoprazole—Dizziness—Telbivudine—hepatitis B	0.000875	0.00173	CcSEcCtD
Lansoprazole—Tremor—Lamivudine—hepatitis B	0.000856	0.00169	CcSEcCtD
Lansoprazole—Ill-defined disorder—Lamivudine—hepatitis B	0.000848	0.00168	CcSEcCtD
Lansoprazole—Anaemia—Lamivudine—hepatitis B	0.000845	0.00167	CcSEcCtD
Lansoprazole—Vomiting—Telbivudine—hepatitis B	0.000842	0.00166	CcSEcCtD
Lansoprazole—Angioedema—Lamivudine—hepatitis B	0.000835	0.00165	CcSEcCtD
Lansoprazole—CYP3A4—liver—hepatitis B	0.000835	0.00916	CbGeAlD
Lansoprazole—Rash—Telbivudine—hepatitis B	0.000835	0.00165	CcSEcCtD
Lansoprazole—Dermatitis—Telbivudine—hepatitis B	0.000834	0.00165	CcSEcCtD
Lansoprazole—Headache—Telbivudine—hepatitis B	0.000829	0.00164	CcSEcCtD
Lansoprazole—Malaise—Lamivudine—hepatitis B	0.000824	0.00163	CcSEcCtD
Lansoprazole—CYP2D6—liver—hepatitis B	0.000822	0.00902	CbGeAlD
Lansoprazole—Vertigo—Lamivudine—hepatitis B	0.000821	0.00162	CcSEcCtD
Lansoprazole—Syncope—Lamivudine—hepatitis B	0.00082	0.00162	CcSEcCtD
Lansoprazole—Leukopenia—Lamivudine—hepatitis B	0.000818	0.00162	CcSEcCtD
Lansoprazole—Loss of consciousness—Lamivudine—hepatitis B	0.000803	0.00159	CcSEcCtD
Lansoprazole—Cough—Lamivudine—hepatitis B	0.000798	0.00158	CcSEcCtD
Lansoprazole—Convulsion—Lamivudine—hepatitis B	0.000792	0.00157	CcSEcCtD
Lansoprazole—Nausea—Telbivudine—hepatitis B	0.000786	0.00155	CcSEcCtD
Lansoprazole—Arthralgia—Lamivudine—hepatitis B	0.000778	0.00154	CcSEcCtD
Lansoprazole—Myalgia—Lamivudine—hepatitis B	0.000778	0.00154	CcSEcCtD
Lansoprazole—Chest pain—Lamivudine—hepatitis B	0.000778	0.00154	CcSEcCtD
Lansoprazole—Anxiety—Lamivudine—hepatitis B	0.000776	0.00153	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000773	0.00153	CcSEcCtD
Lansoprazole—Discomfort—Lamivudine—hepatitis B	0.000769	0.00152	CcSEcCtD
Lansoprazole—Dry mouth—Lamivudine—hepatitis B	0.000761	0.00151	CcSEcCtD
Lansoprazole—ABCB1—blood—hepatitis B	0.000756	0.00829	CbGeAlD
Lansoprazole—Confusional state—Lamivudine—hepatitis B	0.000752	0.00149	CcSEcCtD
Lansoprazole—Oedema—Lamivudine—hepatitis B	0.000746	0.00148	CcSEcCtD
Lansoprazole—Anaphylactic shock—Lamivudine—hepatitis B	0.000746	0.00148	CcSEcCtD
Lansoprazole—Infection—Lamivudine—hepatitis B	0.000741	0.00147	CcSEcCtD
Lansoprazole—Shock—Lamivudine—hepatitis B	0.000734	0.00145	CcSEcCtD
Lansoprazole—Nervous system disorder—Lamivudine—hepatitis B	0.000732	0.00145	CcSEcCtD
Lansoprazole—Thrombocytopenia—Lamivudine—hepatitis B	0.00073	0.00144	CcSEcCtD
Lansoprazole—Skin disorder—Lamivudine—hepatitis B	0.000725	0.00143	CcSEcCtD
Lansoprazole—Hyperhidrosis—Lamivudine—hepatitis B	0.000721	0.00143	CcSEcCtD
Lansoprazole—Anorexia—Lamivudine—hepatitis B	0.000711	0.00141	CcSEcCtD
Lansoprazole—Hypotension—Lamivudine—hepatitis B	0.000697	0.00138	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00068	0.00134	CcSEcCtD
Lansoprazole—Insomnia—Lamivudine—hepatitis B	0.000675	0.00133	CcSEcCtD
Lansoprazole—Paraesthesia—Lamivudine—hepatitis B	0.00067	0.00132	CcSEcCtD
Lansoprazole—Dyspnoea—Lamivudine—hepatitis B	0.000665	0.00132	CcSEcCtD
Lansoprazole—Somnolence—Lamivudine—hepatitis B	0.000663	0.00131	CcSEcCtD
Lansoprazole—Dyspepsia—Lamivudine—hepatitis B	0.000657	0.0013	CcSEcCtD
Lansoprazole—Decreased appetite—Lamivudine—hepatitis B	0.000649	0.00128	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000644	0.00127	CcSEcCtD
Lansoprazole—Fatigue—Lamivudine—hepatitis B	0.000643	0.00127	CcSEcCtD
Lansoprazole—Pain—Lamivudine—hepatitis B	0.000638	0.00126	CcSEcCtD
Lansoprazole—Constipation—Lamivudine—hepatitis B	0.000638	0.00126	CcSEcCtD
Lansoprazole—Feeling abnormal—Lamivudine—hepatitis B	0.000615	0.00122	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Lamivudine—hepatitis B	0.00061	0.00121	CcSEcCtD
Lansoprazole—Urticaria—Lamivudine—hepatitis B	0.000593	0.00117	CcSEcCtD
Lansoprazole—ABCB1—liver—hepatitis B	0.000591	0.00648	CbGeAlD
Lansoprazole—Abdominal pain—Lamivudine—hepatitis B	0.00059	0.00117	CcSEcCtD
Lansoprazole—Body temperature increased—Lamivudine—hepatitis B	0.00059	0.00117	CcSEcCtD
Lansoprazole—Hypersensitivity—Lamivudine—hepatitis B	0.00055	0.00109	CcSEcCtD
Lansoprazole—Asthenia—Lamivudine—hepatitis B	0.000535	0.00106	CcSEcCtD
Lansoprazole—Pruritus—Lamivudine—hepatitis B	0.000528	0.00104	CcSEcCtD
Lansoprazole—Diarrhoea—Lamivudine—hepatitis B	0.00051	0.00101	CcSEcCtD
Lansoprazole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000499	0.00325	CbGpPWpGaD
Lansoprazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000497	0.00323	CbGpPWpGaD
Lansoprazole—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000496	0.00322	CbGpPWpGaD
Lansoprazole—Dizziness—Lamivudine—hepatitis B	0.000493	0.000976	CcSEcCtD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000483	0.00314	CbGpPWpGaD
Lansoprazole—CYP1A2—Phase II conjugation—GGT2—hepatitis B	0.000475	0.00309	CbGpPWpGaD
Lansoprazole—Vomiting—Lamivudine—hepatitis B	0.000474	0.000938	CcSEcCtD
Lansoprazole—Rash—Lamivudine—hepatitis B	0.00047	0.00093	CcSEcCtD
Lansoprazole—Dermatitis—Lamivudine—hepatitis B	0.00047	0.000929	CcSEcCtD
Lansoprazole—Headache—Lamivudine—hepatitis B	0.000467	0.000924	CcSEcCtD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000467	0.00304	CbGpPWpGaD
Lansoprazole—MAPT—Alzheimers Disease—TP53—hepatitis B	0.000463	0.00301	CbGpPWpGaD
Lansoprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000462	0.003	CbGpPWpGaD
Lansoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000458	0.00298	CbGpPWpGaD
Lansoprazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000456	0.00296	CbGpPWpGaD
Lansoprazole—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000456	0.00296	CbGpPWpGaD
Lansoprazole—CYP2C18—Biological oxidations—GGT1—hepatitis B	0.000454	0.00295	CbGpPWpGaD
Lansoprazole—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.000454	0.00295	CbGpPWpGaD
Lansoprazole—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000452	0.00294	CbGpPWpGaD
Lansoprazole—CYP1A1—Metapathway biotransformation—AKR1B1—hepatitis B	0.000449	0.00292	CbGpPWpGaD
Lansoprazole—Nausea—Lamivudine—hepatitis B	0.000443	0.000876	CcSEcCtD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00044	0.00286	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—GGT2—hepatitis B	0.000436	0.00283	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—CTNNB1—hepatitis B	0.000431	0.0028	CbGpPWpGaD
Lansoprazole—CYP1B1—Biological oxidations—CYP2A6—hepatitis B	0.000429	0.00279	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—NFKB1—hepatitis B	0.000418	0.00272	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000415	0.0027	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000415	0.0027	CbGpPWpGaD
Lansoprazole—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000414	0.00269	CbGpPWpGaD
Lansoprazole—CYP2C8—Metapathway biotransformation—AKR1B1—hepatitis B	0.000411	0.00267	CbGpPWpGaD
Lansoprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000407	0.00265	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—CTNNB1—hepatitis B	0.000406	0.00264	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—GGT2—hepatitis B	0.0004	0.0026	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000391	0.00254	CbGpPWpGaD
Lansoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000391	0.00254	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000389	0.00253	CbGpPWpGaD
Lansoprazole—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000386	0.00251	CbGpPWpGaD
Lansoprazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000374	0.00243	CbGpPWpGaD
Lansoprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000371	0.00241	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—NFKB1—hepatitis B	0.00037	0.0024	CbGpPWpGaD
Lansoprazole—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000367	0.00239	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000357	0.00232	CbGpPWpGaD
Lansoprazole—CYP1A2—Arachidonic acid metabolism—GGT1—hepatitis B	0.000353	0.0023	CbGpPWpGaD
Lansoprazole—CYP1A1—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000346	0.00225	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000344	0.00223	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.000344	0.00223	CbGpPWpGaD
Lansoprazole—CYP2D6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000338	0.00219	CbGpPWpGaD
Lansoprazole—CYP1A1—Oxidative Stress—NFKB1—hepatitis B	0.000337	0.00219	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000336	0.00218	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000335	0.00218	CbGpPWpGaD
Lansoprazole—CYP1B1—Biological oxidations—GGT1—hepatitis B	0.000335	0.00218	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000335	0.00218	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000334	0.00217	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—GGT2—hepatitis B	0.000328	0.00213	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000325	0.00212	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000324	0.0021	CbGpPWpGaD
Lansoprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000317	0.00206	CbGpPWpGaD
Lansoprazole—ABCG2—Fluoropyrimidine Activity—TP53—hepatitis B	0.000316	0.00206	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TGFB1—hepatitis B	0.000308	0.002	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—TNF—hepatitis B	0.000307	0.00199	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000302	0.00196	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000302	0.00196	CbGpPWpGaD
Lansoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000302	0.00196	CbGpPWpGaD
Lansoprazole—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000298	0.00194	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000288	0.00187	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TNF—hepatitis B	0.000287	0.00187	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—AKR1B1—hepatitis B	0.000286	0.00186	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—ALB—hepatitis B	0.000285	0.00185	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000284	0.00184	CbGpPWpGaD
Lansoprazole—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000283	0.00184	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—GGT2—hepatitis B	0.000278	0.00181	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000278	0.00181	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—TP53—hepatitis B	0.00027	0.00176	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—CYP2A6—hepatitis B	0.000264	0.00172	CbGpPWpGaD
Lansoprazole—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000261	0.00169	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000259	0.00169	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000256	0.00166	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—ALB—hepatitis B	0.000254	0.00165	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL10—hepatitis B	0.000253	0.00165	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—CD40LG—hepatitis B	0.000253	0.00165	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TP53—hepatitis B	0.000253	0.00165	CbGpPWpGaD
Lansoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000245	0.00159	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—CYP2A6—hepatitis B	0.000242	0.00157	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000241	0.00157	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000239	0.00156	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—FASLG—hepatitis B	0.000236	0.00153	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000229	0.00149	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—FAS—hepatitis B	0.000227	0.00148	CbGpPWpGaD
Lansoprazole—CYP1A2—Phase II conjugation—GGT1—hepatitis B	0.000225	0.00146	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000224	0.00146	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.000223	0.00145	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000221	0.00144	CbGpPWpGaD
Lansoprazole—CYP1A2—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000221	0.00143	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000216	0.00141	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000215	0.00139	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000206	0.00134	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—GGT1—hepatitis B	0.000206	0.00134	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000204	0.00133	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.0002	0.0013	CbGpPWpGaD
Lansoprazole—CYP4A11—NRF2 pathway—TGFB1—hepatitis B	0.000199	0.0013	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000199	0.0013	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	0.000199	0.00129	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000197	0.00128	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AKR1B1—hepatitis B	0.000196	0.00127	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—GGT1—hepatitis B	0.000189	0.00123	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GGT2—hepatitis B	0.000188	0.00122	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000186	0.00121	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000186	0.00121	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000183	0.00119	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000175	0.00114	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AKR1B1—hepatitis B	0.000171	0.00111	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000169	0.0011	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	0.000168	0.0011	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GGT2—hepatitis B	0.000164	0.00107	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000163	0.00106	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00016	0.00104	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000155	0.00101	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000154	0.001	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000154	0.000999	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000153	0.000992	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IFNG—hepatitis B	0.000149	0.000969	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000143	0.000929	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL2—hepatitis B	0.000132	0.000861	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—GGT1—hepatitis B	0.000132	0.000855	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00013	0.000847	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.00013	0.000845	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000129	0.000836	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000127	0.000826	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AKR1B1—hepatitis B	0.000126	0.000821	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GGT2—hepatitis B	0.000121	0.000787	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000119	0.000771	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000119	0.000771	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000116	0.000756	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AKR1B1—hepatitis B	0.000115	0.000747	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CYP2A6—hepatitis B	0.000114	0.00074	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000112	0.000729	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000111	0.000724	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GGT2—hepatitis B	0.00011	0.000716	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000106	0.00069	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—TGFB1—hepatitis B	0.000103	0.000671	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GOT2—hepatitis B	0.000103	0.000669	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000102	0.00066	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CYP2A6—hepatitis B	9.95e-05	0.000647	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—TNF—hepatitis B	9.65e-05	0.000627	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GOT2—hepatitis B	9e-05	0.000585	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GGT1—hepatitis B	8.89e-05	0.000578	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GOT1—hepatitis B	8.89e-05	0.000578	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	8.1e-05	0.000527	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	7.92e-05	0.000515	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKR1B1—hepatitis B	7.78e-05	0.000506	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GGT1—hepatitis B	7.77e-05	0.000505	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GOT1—hepatitis B	7.77e-05	0.000505	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GGT2—hepatitis B	7.46e-05	0.000485	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CYP2A6—hepatitis B	7.34e-05	0.000477	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	7.26e-05	0.000472	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKR1B1—hepatitis B	7.13e-05	0.000464	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	6.84e-05	0.000445	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GGT2—hepatitis B	6.84e-05	0.000444	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CYP2A6—hepatitis B	6.68e-05	0.000434	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GOT2—hepatitis B	6.64e-05	0.000431	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	6.48e-05	0.000421	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKR1B1—hepatitis B	6.37e-05	0.000414	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	6.31e-05	0.00041	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKR1B1—hepatitis B	6.21e-05	0.000404	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	6.16e-05	0.000401	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	6.15e-05	0.0004	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	6.12e-05	0.000398	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GGT2—hepatitis B	6.1e-05	0.000397	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GOT2—hepatitis B	6.04e-05	0.000392	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GGT2—hepatitis B	5.96e-05	0.000387	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—ALB—hepatitis B	5.92e-05	0.000385	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	5.91e-05	0.000384	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKR1B1—hepatitis B	5.86e-05	0.000381	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKR1B1—hepatitis B	5.81e-05	0.000377	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GGT1—hepatitis B	5.73e-05	0.000372	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GOT1—hepatitis B	5.73e-05	0.000372	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GGT2—hepatitis B	5.61e-05	0.000365	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GGT2—hepatitis B	5.57e-05	0.000362	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	5.22e-05	0.000339	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GGT1—hepatitis B	5.21e-05	0.000339	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GOT1—hepatitis B	5.21e-05	0.000339	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	5.1e-05	0.000331	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	5.05e-05	0.000328	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKR1B1—hepatitis B	4.96e-05	0.000322	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	4.76e-05	0.000309	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GGT2—hepatitis B	4.76e-05	0.000309	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ALB—hepatitis B	4.73e-05	0.000307	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP2A6—hepatitis B	4.52e-05	0.000294	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.21e-05	0.000274	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	4.2e-05	0.000273	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP2A6—hepatitis B	4.14e-05	0.000269	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ALB—hepatitis B	4.13e-05	0.000269	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GOT2—hepatitis B	4.09e-05	0.000266	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.86e-05	0.000251	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKR1B1—hepatitis B	3.83e-05	0.000249	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GOT2—hepatitis B	3.75e-05	0.000244	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP2A6—hepatitis B	3.7e-05	0.00024	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GGT2—hepatitis B	3.67e-05	0.000239	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP2A6—hepatitis B	3.61e-05	0.000235	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTEN—hepatitis B	3.61e-05	0.000234	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GOT1—hepatitis B	3.53e-05	0.000229	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GGT1—hepatitis B	3.53e-05	0.000229	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.45e-05	0.000224	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP2A6—hepatitis B	3.4e-05	0.000221	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP2A6—hepatitis B	3.37e-05	0.000219	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GOT2—hepatitis B	3.34e-05	0.000217	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GOT2—hepatitis B	3.26e-05	0.000212	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GGT1—hepatitis B	3.23e-05	0.00021	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GOT1—hepatitis B	3.23e-05	0.00021	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.21e-05	0.000209	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	3.2e-05	0.000208	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTEN—hepatitis B	3.15e-05	0.000205	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.14e-05	0.000204	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GOT2—hepatitis B	3.08e-05	0.0002	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GOT2—hepatitis B	3.05e-05	0.000198	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ALB—hepatitis B	3.05e-05	0.000198	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.95e-05	0.000192	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GGT1—hepatitis B	2.89e-05	0.000188	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GOT1—hepatitis B	2.89e-05	0.000188	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP2A6—hepatitis B	2.88e-05	0.000187	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GGT1—hepatitis B	2.82e-05	0.000183	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GOT1—hepatitis B	2.82e-05	0.000183	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALB—hepatitis B	2.77e-05	0.00018	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.69e-05	0.000175	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GOT1—hepatitis B	2.66e-05	0.000173	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GGT1—hepatitis B	2.66e-05	0.000173	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GGT1—hepatitis B	2.63e-05	0.000171	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GOT1—hepatitis B	2.63e-05	0.000171	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.63e-05	0.000171	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GOT2—hepatitis B	2.61e-05	0.000169	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.4e-05	0.000156	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTEN—hepatitis B	2.32e-05	0.000151	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GOT1—hepatitis B	2.25e-05	0.000146	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GGT1—hepatitis B	2.25e-05	0.000146	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP2A6—hepatitis B	2.22e-05	0.000145	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTEN—hepatitis B	2.12e-05	0.000137	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.05e-05	0.000133	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GOT2—hepatitis B	2.01e-05	0.000131	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—hepatitis B	1.88e-05	0.000122	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GOT1—hepatitis B	1.74e-05	0.000113	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GGT1—hepatitis B	1.74e-05	0.000113	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—hepatitis B	1.72e-05	0.000112	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—hepatitis B	1.54e-05	9.98e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—hepatitis B	1.5e-05	9.74e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTEN—hepatitis B	1.43e-05	9.31e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—hepatitis B	1.41e-05	9.18e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—hepatitis B	1.4e-05	9.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTEN—hepatitis B	1.31e-05	8.53e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—hepatitis B	1.2e-05	7.78e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTEN—hepatitis B	1.17e-05	7.61e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTEN—hepatitis B	1.14e-05	7.43e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTEN—hepatitis B	1.08e-05	7e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTEN—hepatitis B	1.07e-05	6.94e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—hepatitis B	9.23e-06	6e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTEN—hepatitis B	9.13e-06	5.93e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTEN—hepatitis B	7.05e-06	4.58e-05	CbGpPWpGaD
